Skip to main content
. 2022 May 2;28(4):523–531. doi: 10.1111/hae.14570

FIGURE 1.

FIGURE 1

Modelled mean plasma concentration of factor X activity (clotting) following (A) a single intravenous 25 IU/kg dose of plasma‐derived factor X concentrate and (B) twice‐weekly administration of 20, 25, or 30 IU/kg plasma‐derived factor X concentrate 18